m3C is a mitochondrial mRNA modification which promotes tumor progression
Audrey Penning, Kun Wang, Margot Celerier, Évelyne Collignon, Irina Primac, Louis Van der Linden, Martin Bizet, Emilie Calonne, Bouchra Hassabi, Céline Hubert, Pascale Putmans, Frédéric Murisier, Lionel Larbanoix, Younès Achouri, Jie Lan, , François Fuks
This study identifies m3C as a novel mitochondrial mRNA modification catalyzed by METTL8, which promotes tumor progression by enhancing complex I activity and oncogenic pathways.
bioRxiv · Jan 15, 2025 · PreprintCell Biology